Drugs that contain Levalbuterol Tartrate

1. Drug name - XOPENEX HFA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7256310 SUNOVION Levalbuterol salt
Oct, 2024

(2 years from now)

EP1671942B1 SUNOVION Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt
Dec, 2023

(1 year, 2 months from now)

EP1572622A1 SUNOVION Use Of Levalbuterol L-Tartrate In The Production Of A Metered Dose Inhaler
Dec, 2023

(1 year, 2 months from now)

EP2292584B1 SUNOVION Pharmaceutical Composition Comprising Levalbuterol L-Hemitartrate Salt As Aerosol Formulation
Dec, 2023

(1 year, 2 months from now)

EP2292584A1 SUNOVION Pharmaceutical Composition Comprising Levalbuterol L-Hemitartrate Salt As Aerosol Formulation
Dec, 2023

(1 year, 2 months from now)

EP1671942A1 SUNOVION Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt
Dec, 2023

(1 year, 2 months from now)

EP1572622B1 SUNOVION Use Of Levalbuterol L-Tartrate In The Production Of A Metered Dose Inhaler
Dec, 2023

(1 year, 2 months from now)

EP1671942B2 SUNOVION Aerosol Formulation Comprising Levalbuterol L-Tartrate Salt
Dec, 2023

(1 year, 2 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765153 SUNOVION Levalbuterol salt Dec, 2023

(1 year, 2 months from now)

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
EQ 0.045MG BASE/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.